This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.

Background to renal cell carcinoma

Renal Cell Carcinoma File
19 pages

Pathology of kidney cancer and renal cell carcinoma (RCC). Epidemiology of kidney cancer and RCC. Staging and prognosis of RCC. Treatment of RCC.

CBZ-UK-000340 | November 2024

Background to renal cell carcinoma
Explore more Renal Cell Carcinoma Resources

Explore more Renal Cell Carcinoma Resources

Browse